Nve Corp /new/ (NVEC) · Oct 21, 2026 · Earnings
Miss — Q2 diluted EPS $0.65 vs $0.68 prior year; no dependable published consensus
NVE Corporation earnings show a sharp Q2 revenue reversal despite strong first-half growth; its routine $1 dividend remains unchanged.
NVE is a small spintronics manufacturer selling sensors and couplers into industrial, scientific, and medical applications, with growth tied mainly to expanding product sales rather than a broad platform transition.
The current quarter is the warning sign. Q2 revenue fell 8% year over year to $5.83 million, driven by a 9% decline in product sales; contract research and development revenue rose 25% but was too small to offset the product weakness. The result is weaker than the business trajectory implied by Q1’s 81% revenue surge, although no dependable published consensus was available for this thinly covered company.
Profitability also softened, but the six-month picture remains strong. Quarterly net income declined 4% to $3.17 million, or $0.65 diluted EPS, while first-half revenue rose 36% and net income rose 39% to $9.57 million. That makes this a mixed operating update: the first half is materially ahead of last year, but the latest quarter raises questions about whether the Q1 product demand spike was durable.
The dividend adds no new signal. NVE declared another $1.00-per-share quarterly payment for November 30, consistent with its long-running quarterly payout rather than an increase or a new capital-allocation decision. The balance sheet still shows substantial cash and marketable securities relative to liabilities, supporting the payment, but the dividend does not change the underlying growth read.
Financial snapshot (Statements of Income / Balance Sheets)
| Metric | Q2 FY2027 | Q2 FY2026 | Six months FY2027 | Six months FY2026 |
|---|---|---|---|---|
| Revenue | $5.83M | $6.35M | $16.87M | $12.45M |
| Net income | $3.17M | $3.31M | $9.57M | $6.89M |
| Diluted EPS | $0.65 | $0.68 | $1.97 | $1.42 |
| Cash and cash equivalents | $3.97M | — | — | — |
| Marketable securities, short- and long-term | $40.42M | — | — | — |
Bottom line: The filing turns a previously strong fiscal-year growth story into a more cautious one: first-half results are excellent, but the latest quarter shows product demand retreating and earnings slipping. The unchanged dividend is reassuring financially but already routine, so the key issue is whether Q2 was a pause or the start of a broader slowdown.
Q3 earnings report
A buy-side analyst on every ticker — it reads every public company's filing the instant it drops and decodes it into plain English.
A buy-side analyst on every ticker — the whole market decoded the second it moves, before it's a headline. Free gives you a taste. Pro takes the cap off and opens the full read on every company.
by Signing in NOW, claim your FREE 14-day Pro trial!